Shenzhen Lifotronic Technology Co., Ltd. (SHA: 688389)

Market Cap	6.21B
Revenue (ttm)	1.19B
Net Income (ttm)	381.08M
Shares Out	428.44M
EPS (ttm)	0.89
PE Ratio	16.29
Forward PE	15.21
Dividend	0.28 (1.89%)
Ex-Dividend Date	n/a

Volume	2,687,207
Open	14.95
Previous Close	14.89
Day's Range	14.60 - 15.02
52-Week Range	12.27 - 21.75
Beta	0.44
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 11, 2025

About Shenzhen Lifotronic Technology

Shenzhen Lifotronic Technology Co., Ltd. research, develops, manufactures, and markets medical devices for diagnostics, clinical medicine, skin, and human health related purposes in China. The company offers IVD products, such as HPLC, ECLIA, and hematology system; rapid test, molecular and POCT diagnostics. It also offers therapeutic products comprising respiratory and ICU, and wound care; electromagnetic and pneumatic shockwave products. In addition, the company provides medical and aesthetic, and laser hair removal products, as well as offer...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2008
• Employees: 1,481
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688389

Financial Performance

In 2023, Shenzhen Lifotronic Technology's revenue was 1.15 billion, an increase of 16.55% compared to the previous year's 983.04 million. Earnings were 328.58 million, an increase of 30.66%.